CytoreductiveSurgery & HIPEC w/Gemcitabine+Chemotherapy w/Dacarbazine in Uterine Leiomyosarcoma

Clinical trial NCT04727242 · COMPLETED

Trial details

NCT number: NCT04727242
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

LMS - Leiomyosarcoma Uterine Leiomyosarcoma

Start date: 2021-01-28
Primary completion: 2026-01-28
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.